Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
Relapsed/refractory AML patients have a poor prognosis, with CR rates of 1–30%, unless allogeneic hematopoietic stem cell transplantation (HSCT) is an available option [...]